Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 8,119,093
- Share change
- +110,538
- Total reported value
- $91,824,177
- Price per share
- $11.31
- Number of holders
- 40
- Value change
- -$276,502
- Number of buys
- 24
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
4%
|
2,518,198
|
$32,258,000 | — | 31 Mar 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
1,656,076
|
$21,214,000 | — | 31 Mar 2017 | |
| Pharmstandard International S.A. |
13F
|
Company |
1.6%
|
982,270
|
$12,583,000 | — | 31 Mar 2017 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.1%
|
683,600
|
$8,757,000 | — | 31 Mar 2017 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1%
|
636,248
|
$8,150,000 | — | 31 Mar 2017 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
0.55%
|
346,281
|
$4,436,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.55%
|
345,645
|
$4,427,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.5%
|
313,514
|
$4,016,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
101,218
|
$1,296,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
93,063
|
$1,192,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
79,666
|
$1,020,000 | — | 31 Mar 2017 | |
| Graticule Asia Macro Advisors LLC |
13F
|
Company |
0.05%
|
31,827
|
$408,000 | — | 31 Mar 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.05%
|
31,500
|
$403,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
26,148
|
$335,000 | — | 31 Mar 2017 | |
| Polar Capital LLP |
13F
|
Company |
0.04%
|
25,000
|
$320,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
19,560
|
$251,000 | — | 31 Mar 2017 | |
| PDT Partners, LLC |
13F
|
Company |
0.03%
|
18,000
|
$231,000 | — | 31 Mar 2017 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
15,300
|
$196,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
13,200
|
$170,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
9,901
|
$127,000 | — | 31 Mar 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.02%
|
9,461
|
$121,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
9,197
|
$118,000 | — | 31 Mar 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
7,601
|
$97,000 | — | 31 Mar 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
7,227
|
$93,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
6,545
|
$83,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,219
|
$67,000 | — | 31 Mar 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,564
|
$58,000 | — | 31 Mar 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.01%
|
4,345
|
$56,000 | — | 31 Mar 2017 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,400
|
$30,000 | — | 31 Mar 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,635
|
$20,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,343
|
$17,000 | — | 31 Mar 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,027
|
$13,000 | — | 31 Mar 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
656
|
$9,000 | — | 31 Mar 2017 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
514
|
$7,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
329
|
$4,000 | — | 31 Mar 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
243
|
$3,000 | — | 31 Mar 2017 | |
| Creative Planning |
13F
|
Company |
0%
|
177
|
$2,000 | — | 31 Mar 2017 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
144
|
$2,000 | — | 31 Mar 2017 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
54
|
$1,000 | — | 31 Mar 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
21
|
$269 | — | 31 Mar 2017 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q2 2017
As of 30 Jun 2017,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,119,093 shares.
The largest 10 holders included
FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pharmstandard International S.A., Cormorant Asset Management, LLC, BlackRock Inc., VANGUARD GROUP INC, SENZAR ASSET MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
39
Q2 2017 holders
40
Holder diff
1
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.